Pharmacodynamic and Clinical Outcome Study of Mongersen in Patients With Crohn's Disease

NCT02685683 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
18
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated by Sponsor following a recommendation from external DMC to terminate the ongoing Phase 3 CD studies; there were no new emergent safety findings

Conditions

Interventions

Sponsor

Celgene